Kerry Wentworth
CIK 1369453 · CHIEF REGULATORY OFFICER · last filed 2026-06-24
Kerry Wentworth is a CHIEF REGULATORY OFFICER who has filed 75 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for NUVB, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $373.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$373.6K
4
75
-$1.58M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | CHIEF REGULATORY OFFICER | 53,000 | $6.68 | $354.1K | -$1.47M | 4 | 2026-06-24 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | CHIEF REGULATORY OFFICER | 50,000 | $0.01 | $255 | $89.7K | 6 | 2025-06-18 |
| FLXN | Chief Regulatory Officer | 0 | $24.66 | $0 | -$109.1K | 17 | 2021-11-19 |
| AGEN | VP, Clinical, Reg & Qual | 2,870 | $6.81 | $19.6K | -$90.9K | 45 | 2014-02-28 |
Recent Filings
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | NUVB | Mixed | — | -$194.6K | EDGAR |
| 2026-06-23 | NUVB | Notice (144) | −63,000 | -$362.9K | EDGAR |
| 2026-04-21 | NUVB | Mixed | — | -$76.6K | EDGAR |
| 2026-04-17 | NUVB | Notice (144) | −36,750 | -$176.8K | EDGAR |
| 2026-04-08 | NUVB | Mixed | — | -$522.6K | EDGAR |
| 2026-04-06 | NUVB | Notice (144) | −200,000 | -$882.0K | EDGAR |
| 2026-03-03 | NUVB | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | Nuvation Bio Inc. (NUVB.WS) Delisted | Buy (P) | +50,000 | $89.7K | EDGAR |
| 2025-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.